The U.S. Food and Drug Administration on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients. The news comes a day after the FDA gave the go-ahead to a similar treatment from Pfizer Inc for high-risk patients above the age of 12. Molnupiravir's emergency approval was supported by a clinical […]